Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 14, 2005; 11(14): 2101-2108
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2101
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2101
Group (n = 3) | Time (h) | Tumor absorbed dose (Gy) | Pc-3 apoptosis rate1(%) | SNK |
15 | 6 | 7.25±2.58 | 10.00±3.02 | A |
16 | 12 | 13.73±2.43 | 17.93±2.24 | B |
17 | 24 | 24.82±5.14 | 33.85±4.54 | C |
18 | 36 | 46.06±8.55 | 27.85±3.04 | D |
19 | 48 | 47.43±11.60 | 18.41±5.40 | E |
- Citation: Liu L, Feng GS, Gao H, Tong GS, Wang Y, Gao W, Huang Y, Li C. Chromic-P32 phosphate treatment of implanted pancreatic carcinoma: Mechanism involved. World J Gastroenterol 2005; 11(14): 2101-2108
- URL: https://www.wjgnet.com/1007-9327/full/v11/i14/2101.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i14.2101